Latest

Latest immunotherapy News

  • Latest immunotherapy news stories and updates. What is happening today? All recent immunotherapy news and developments. Live coverage and timeline of immunotherapy. All you need to know about immunotherapy.
Call For Stem Cell Donors
Recent Advances In Oesophageal Cancer
New centre for immuno-oncology at Karolinska Institutet to bring cancer research closer to new treatments
Victorian researchers awarded $2.25 million to develop kinder childhood cancer treatments
Enhertu demonstrated a median progression-free survival of 14.3 months as 1st-line therapy in patients with HER2-mutant advanced non-small cell lung cancer in…
Update on SERENA-4 Phase III trial of Etcamah in combination with palbociclib in upfront 1st-line advanced ER-positive breast cancer
Funding for health projects to drive more personalised care
The Savén Family contributes to KI’s major initiative in radiation therapy
Immunotherapy Access Expanded Following Epworth Trial
Expansion of immunotherapy PBS listing to treat multiple new cancers
Government funds medicine for approximately 10,000 eligible Australians with certain advanced or metastatic cancers
Cancer’s Malignant Remote Control
Developing a genetic toolkit for manipulating intestinal microbes
Immunotherapy shows promise for clearing residual melanoma cells
Hands-on cancer research: MS Wissenschaft is coming to Würzburg
Blood-Camouflaged Liquid Metal Nanoparticles Defeat the Most Aggressive Breast Cancer
Blood test may help guide treatment for metastatic melanoma
Enhertu demonstrated statistically significant and clinically meaningful improvement in progression-free survival as 1st-line treatment of patients with HER2-mutant advanced non-small cell lung…
Update on eVOLVE-Lung02 Phase III trial of volrustomig plus chemotherapy in metastatic non-small cell lung cancer
New knowledge could make cancer immunotherapy more effective
Aravax Awarded FDA Fast Track Designation for PVX108, a Next-Generation Immunotherapy for the Treatment of Peanut Allergy
CCC Allianz WERA Receives Further Funding
Scientists unmask immune cells that supercharge the fight against cancer
August PBS listings include first new treatment in 20 years for rare brain cancer
Datroway approved in the EU as only TROP2-directed medicine with overall survival benefit for the 1st-line treatment of patients with metastatic TNBC…
Three nurse innovators named as finalists for the 2026 Health Minister’s Award for Nursing Trailblazers
Ivermectin isn’t a cancer miracle drug, but influencers claim otherwise – here’s how to avoid sprinting past scientific evidence
Australian cancer trials are getting worse at reporting sex differences – putting patients at risk
Björn Gysell is donating to research into future treatments for prostate cancer
Three clinical scholars appointed to the Ludwig Institute for Cancer Research
Datroway recommended for approval in the EU by CHMP as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not…
Immunotherapy may temporarily restore fertility in patients of premature menopause
Professor Mohamed Shamji Assumes Presidency of EAACI as Congress 2026 Concludes in Istanbul
Recipients Of CIMED Project Grants 2027-2029 At MedH
Three young researchers backed to change the future for Aussie kids with deadly cancers
Backing Research Into New Treatments For Children’s Cancer
World’s largest genetic study of ‘moliness’ helps unravel mysteries of melanoma
Some immune cells can limit the effect of cancer immunotherapy
Experimental treatment kills prostate tumor cells while reawakening antitumor immunity
Björn Gysell and Family donate 80 million to research on future prostate cancer therapy
New acute care and cancer treatment services for Dargaville
EAACI Calls for a “Vision Zero” Future Free from Allergy and Asthma Burden
AMA President’s update: King’s Birthday Honours, bulk billing assignment changes, RSV, residential aged care, and more
Kanvas Biosciences raises $48 million to advance microbiome cancer therapies
Hay fever, antihistamines and the evidence on dementia risk
Radiotherapy Provides Benefit In Advanced Melanoma
Yes, you really can be allergic to exercise – and the symptoms can be serious
‘Incredible’ Hodgkin Lymphoma Clinical Trial Study

© 2026 - The National Tribune Australia